lobbying_activities: 2468137
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2468137 | fc3d44d0-d43d-4773-812b-a723e2ec1d1f | Q2 | TWENTY-FIRST CENTURY GROUP, INC. | 38687 | CORNERSTONE PHARMACEUTICALS INC. (FORMERLY RAFAEL PHARMACEUTICALS, INC.) | 2020 | second_quarter | MED | Issues related to cancer research and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2020-07-16T12:07:24.160000-04:00 |